Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 21 04:00PM ET
4.05
Dollar change
-0.04
Percentage change
-0.98
%
Index- P/E- EPS (ttm)-0.69 Insider Own41.87% Shs Outstand99.20M Perf Week-14.38%
Market Cap401.76M Forward P/E13.21 EPS next Y0.31 Insider Trans0.00% Shs Float57.66M Perf Month21.26%
Income-61.64M PEG- EPS next Q0.52 Inst Own29.75% Short Float1.35% Perf Quarter28.57%
Sales16.68M P/S24.09 EPS this Y84.91% Inst Trans0.98% Short Ratio0.90 Perf Half Y1.76%
Book/sh1.71 P/B2.37 EPS next Y383.97% ROA-33.24% Short Interest0.78M Perf Year102.50%
Cash/sh1.17 P/C3.45 EPS next 5Y- ROE-37.58% 52W Range1.90 - 5.14 Perf YTD-19.00%
Dividend Est.- P/FCF- EPS past 5Y3.28% ROI-37.68% 52W High-21.21% Beta1.27
Dividend TTM- Quick Ratio7.78 Sales past 5Y305.31% Gross Margin- 52W Low113.16% ATR (14)0.29
Dividend Ex-Date- Current Ratio7.78 EPS Y/Y TTM20.78% Oper. Margin-387.84% RSI (14)51.33 Volatility6.13% 7.59%
Employees161 Debt/Eq0.02 Sales Y/Y TTM309.86% Profit Margin-369.50% Recom1.00 Target Price10.17
Option/ShortYes / Yes LT Debt/Eq0.02 EPS Q/Q9.19% Payout- Rel Volume0.80 Prev Close4.09
Sales Surprise-100.00% EPS Surprise-34.19% Sales Q/Q- EarningsMay 13 BMO Avg Volume864.65K Price4.05
SMA20-5.02% SMA5022.75% SMA20021.93% Trades Volume692,273 Change-0.98%
Date Action Analyst Rating Change Price Target Change
May-31-24Initiated BTIG Research Buy $8
Feb-01-19Downgrade UBS Buy → Neutral
Jan-04-19Initiated UBS Buy
Apr-05-18Initiated H.C. Wainwright Buy $18
Mar-23-18Downgrade Credit Suisse Outperform → Neutral
Oct-18-16Initiated Leerink Partners Outperform
Oct-18-16Initiated Jefferies Buy $25
Oct-18-16Initiated Credit Suisse Outperform $18
May-28-24 07:00AM
May-13-24 03:58PM
03:37PM
02:53PM
02:41PM
11:22AM Loading…
11:22AM
08:13AM
08:02AM
08:00AM
07:26AM
07:23AM
06:12AM
06:05AM
06:00AM
05:52AM
10:52PM Loading…
Mar-14-24 10:52PM
07:00AM
Feb-22-24 07:00AM
Feb-21-24 11:16AM
Jan-30-24 09:35AM
Jan-22-24 08:48AM
07:00AM
Jan-18-24 12:00PM
Jan-03-24 12:00PM
08:10AM
Dec-15-23 07:56AM
07:22AM
Dec-05-23 05:59AM
Dec-01-23 07:00AM
Nov-28-23 07:33PM
06:00AM Loading…
Nov-20-23 06:00AM
Nov-07-23 07:00AM
Nov-03-23 08:37AM
07:00AM
Nov-02-23 07:00AM
Oct-27-23 07:00AM
Oct-24-23 09:40AM
Oct-23-23 10:00AM
Oct-20-23 10:00AM
Oct-18-23 08:26AM
Oct-17-23 07:00AM
Oct-05-23 07:00AM
Sep-05-23 01:09PM
08:48AM
07:00AM
Aug-04-23 08:15AM
07:14AM
07:00AM
Jul-28-23 07:00AM
Jul-26-23 07:00AM
Jul-03-23 07:00AM
Jun-30-23 03:13PM
Jun-27-23 07:00AM
Jun-23-23 04:30PM
Jun-16-23 10:45AM
May-04-23 09:02AM
Apr-28-23 07:14AM
07:00AM
Apr-26-23 08:01PM
Apr-07-23 08:29AM
Apr-05-23 07:00AM
Mar-20-23 08:00AM
Mar-16-23 07:00AM
Mar-08-23 07:00AM
Feb-07-23 07:00AM
Feb-02-23 08:15AM
Jan-27-23 09:57AM
Jan-26-23 07:00AM
Jan-18-23 07:00AM
Jan-07-23 08:45AM
Nov-30-22 07:00AM
Nov-25-22 07:17AM
Nov-23-22 07:30AM
Nov-08-22 07:58AM
Oct-29-22 08:06AM
Oct-28-22 09:25AM
08:00AM
Oct-04-22 08:36AM
Sep-26-22 07:30AM
Sep-01-22 08:00AM
Aug-24-22 04:05PM
Aug-11-22 07:30AM
Aug-02-22 11:00AM
Jul-31-22 08:12AM
Jul-28-22 08:45AM
07:30AM
Jul-22-22 07:30AM
Jun-24-22 04:30PM
Jun-21-22 10:35AM
Jun-17-22 08:31AM
Jun-16-22 08:20AM
06:39AM
01:00AM
Jun-01-22 08:26AM
May-31-22 07:30AM
May-17-22 09:00AM
May-09-22 11:00AM
Apr-28-22 07:30AM
Apr-27-22 07:55AM
Apr-08-22 07:30AM
AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.